4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000042
President and CEO sold 9,491 shares at $34.72 ($329,528)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-11 | Sale : show line 1 in the form | −9,491 | $34.72 | $329,528 | 2,129,648 | I |
| Open-market sales · 9,491 sh · avg $34.72 · $329,528 | ||||||
Loading xslF345X03/wf-form4_164496949316138.xml…